As of 4:00pm ET
| +3.47 / +2.53%|
The 16 analysts offering 12-month price forecasts for Jazz Pharmaceuticals PLC have a median target of 191.50, with a high estimate of 210.00 and a low estimate of 137.00. The median estimate represents a +36.26% increase from the last price of 140.54.
The current consensus among 17 polled investment analysts is to Buy stock in Jazz Pharmaceuticals PLC. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.